医学
肺癌
非小细胞肺癌
辅助治疗
卡那努马布
随机对照试验
佐剂
临床试验
双盲
肿瘤科
内科学
癌症
病理
疾病
安慰剂
替代医学
阿纳基纳
A549电池
作者
Edward B. Garon,Shun Lü,Yasushi Goto,Pedro De Marchi,Luis Paz‐Ares,David R. Spigel,Michael Thomas,James Chih‐Hsin Yang,Andrea Ardizzoni,Fabrice Barlési,С. В. Орлов,Hiroshige Yoshioka,Giannis Mountzios,Sadhvi Khanna,Claudia Bossen,Mariana Carbini,Sabine Turri,Andrea P. Myers,Byoung Chul Cho
摘要
CANOPY-A did not show a DFS benefit of adding canakinumab after surgery and adjuvant cisplatin-based chemotherapy in patients with resected, stage II-III NSCLC. No new safety signals were identified with canakinumab.
科研通智能强力驱动
Strongly Powered by AbleSci AI